AnPac Bio-Medical Science Stock (NASDAQ:ANPC)


Chart

Previous Close

$4.44

52W Range

$2.60 - $11.99

50D Avg

$5.05

200D Avg

$5.35

Market Cap

$26.97M

Avg Vol (3M)

$22.07K

Beta

1.56

Div Yield

-

ANPC Company Profile


AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

CN

Employees

89

IPO Date

Jan 30, 2020

Website

ANPC Performance


Latest Earnings Call Transcripts


Q4 20May 01, 21 | 1:01 PM
Q2 20Sep 10, 20 | 5:00 PM

Peer Comparison


TickerCompany
MRNSMarinus Pharmaceuticals, Inc.
SERSerina Therapeutics, Inc.
LSBLakeShore Biopharma Co., Ltd
ALLKAllakos Inc.
LMNLLiminal BioSciences Inc.
GMTXGemini Therapeutics, Inc.
TickerGate Footer Logo

Tickergate is an AI research agent that helps investors analyze companies, filings, and markets faster and smarter.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks